Jasper Therapeutics Inc. Common Stock (JSPR)

About JSPR

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeu…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

22

Website

jaspertx.com/

Fundamentals

1-day range

$0.6601$0.7095

Market cap

$18.10M

P/E (trailing)

—

P/E (forward)

-0.27

EPS (trailing)

$-3.23

Dividend yield

—

Beta

3.21

Avg. volume

1.55M

Forecasts

4 analyst ratings

Jasper Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• JSPR

  Jasper Therapeutics Inc. Common Stock

  $0.6782

  ▼ 2.98%
  Market cap $18.10MP/E —
  $0.3151$2.96
• PLUR

  Pluri Inc. Common Stock

  $1.53

  ▲ 0.00%
  Market cap $19.53MP/E —
  $1.45$5.68
• PASG

  Passage Bio Inc. Common Stock

  $4.52

  ▲ 4.39%
  Market cap $14.11MP/E —
  $3.29$20
• INTS

  Intensity Therapeutics Inc. Common stock

  $4.25

  ▲ 0.95%
  Market cap $11.49MP/E —
  $3.51$43.5
• EVAX

  Evaxion A/S American Depositary Share

  $3.03

  ▼ 3.81%
  Market cap $24.98MP/E —
  $2.52$12.15
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $10.80MP/E —
  $0.75$2.29
• CRIS

  Curis Inc. Common Stock

  $1.49

  ▲ 2.76%
  Market cap $8.59MP/E —
  $1.4$39

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Tuesday's Intraday Session
  Benzinga · 8/18/2026
• Jasper Therapeutics Q2 EPS $(0.10) Beats $(0.26) Estimate
  benzinga · 8/14/2026
• Jasper Therapeutics Q2 EPS $(0.10) Beats $(0.26) Estimate
  Benzinga · 8/14/2026
• Piper Sandler Initiates Coverage On Jasper Therapeutics with Overweight Rating, Announces Price Target of $2
  Benzinga · 8/12/2026
• 12 Health Care Stocks Moving In Tuesday's Intraday Session
  Benzinga · 8/11/2026

• Judith Anne Shizuru · July 31, 2026 · Grant

  7.5K
• Svetlana Lucas · July 31, 2026 · Grant

  7.5K
• Crutcher Patrick J · July 31, 2026 · Grant

  7.5K
• EMSTER KURT VON · July 31, 2026 · Grant

  7.5K
• Thomas G. Wiggans · July 31, 2026 · Grant

  7.5K
• Ros Matthew E · July 20, 2026 · Buy

  881
• Crutcher Patrick J · July 20, 2026 · Buy

  888
• Crutcher Patrick J · July 16, 2026 · Grant

  15.0K

Institutional Ownership

March 31, 2026

Total shares held

15.81M

Total value held

$13.84M

Institutional holders

56